Clinic
Carilion Giles Community Hospital
Carilion Giles Community Hospital was paid $10.32M by Medicaid between Jan 2018 and Dec 2024, across 100 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoCARILION GILES COMMUNITY HOSPITAL
PEARISBURG, VA 24134
PEARISBURG, VA 24134
33aNPI1194718304assigned 08/24/2005
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$10.32M
24GClaims135,232
24DCodes billed100
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Virginia
Rank by total paid#8 of 27
Median peer was paid$349K
This provider vs. median30×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRESCOTT, ELEANOR controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,402 | $604K | |
| 2019 | 15,512 | $961K | |
| 2020 | 18,888 | $1.34M | |
| 2021 | 21,843 | $1.46M | |
| 2022 | 22,472 | $1.65M | |
| 2023 | 24,937 | $2.12M | |
| 2024incomplete | 22,178 | $2.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 9,526 | 8,557 | $2.11M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 10,142 | 8,895 | $1.98M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 4,506 | 3,791 | $1.22M |
| 96361 | Intravenous infusion, hydration; each additional hour | 7.8% | 2,199 | 1,966 | $804K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6.5% | 2,746 | 867 | $674K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.8% | 3,033 | 2,797 | $598K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.7% | 6,781 | 2,238 | $487K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.1% | 1,265 | 1,091 | $418K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.6% | 1,114 | 946 | $269K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.2% | 2,403 | 2,224 | $222K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,096 | 967 | $151K |
| 80053 | Comprehensive metabolic panel | 1.3% | 7,705 | 6,547 | $136K |
88 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.1% | 1,532 | $114K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 4,583 | $87K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,313 | $77K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 359 | $75K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,965 | $58K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,873 | $56K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,038 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 831 | $53K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 261 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,042 | $47K |
| 97162 | <1% | 124 | $38K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 233 | $37K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 116 | $31K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,143 | $28K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 4,428 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,650 | $23K |
| 84484 | <1% | 3,124 | $22K | |
| 73610 | <1% | 564 | $20K | |
| 97161 | <1% | 121 | $20K | |
| 83690 | <1% | 2,119 | $20K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 235 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 699 | $17K |
| 81001 | <1% | 3,206 | $16K | |
| 73030 | <1% | 354 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 770 | $15K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $14K |
| 73130 | <1% | 258 | $13K | |
| 83880 | <1% | 668 | $12K | |
| J8597 | Antiemetic drug, oral, not otherwise specified | <1% | 793 | $11K |
| 20610 | <1% | 287 | $11K | |
| 73630 | <1% | 308 | $10K | |
| 83735 | <1% | 2,234 | $10K | |
| 73110 | <1% | 187 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,363 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,364 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 201 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 3,051 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 715 | $7K |
| 76830 | Ultrasound, transvaginal | <1% | 45 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 112 | $6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 308 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,164 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 16 | $6K |
| 81025 | <1% | 816 | $5K | |
| 84703 | <1% | 1,005 | $5K | |
| 73562 | <1% | 80 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 59 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,042 | $4K |
| 83605 | <1% | 776 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,839 | $4K |
| 87081 | <1% | 1,025 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 44 | $3K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 2,138 | $3K |
| J3490 | Unclassified drugs | <1% | 3,718 | $3K |
| 81003 | <1% | 743 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $2K |
| 82962 | <1% | 945 | $2K | |
| 72100 | <1% | 59 | $2K | |
| 74018 | <1% | 81 | $2K | |
| 96376 | <1% | 216 | $2K | |
| 73564 | <1% | 63 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 599 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 848 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 372 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 76 | $1K |
| 87040 | <1% | 75 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 18 | $864.74 |
| 85379 | <1% | 85 | $808.43 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 16 | $443.07 |
| 80306 | <1% | 125 | $373.66 | |
| 74019 | <1% | 30 | $311.43 | |
| 85610 | <1% | 46 | $221.64 | |
| 87186 | <1% | 26 | $152.51 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 12 | $114.17 |
| 82565 | <1% | 95 | $108.27 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 34 | $64.01 |
| 85730 | <1% | 16 | $27.36 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 131 | $27.19 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 50 | $20.82 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 26 | $14.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 58 | $7.06 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 113 | $2.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $1.65 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 17 | $0.68 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 304 | $0.09 |
| J2704 | Injection, propofol, 10 mg | 0% | 41 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 14 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRESCOTT, ELEANOR (GOVERNMENT PROGRAM MANAGER)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.